REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
8.96
-0.17 (-1.86%)
At close: Jul 25, 2025, 4:00 PM
8.96
0.00 (0.00%)
After-hours: Jul 25, 2025, 6:15 PM EDT

REGENXBIO Stock Forecast

Stock Price Forecast

The 8 analysts that cover REGENXBIO stock have a consensus rating of "Strong Buy" and an average price target of $31.75, which forecasts a 254.35% increase in the stock price over the next year. The lowest target is $12 and the highest is $52.

Price Target: $31.75 (+254.35%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$12$31.75$34$52
Change+33.93%+254.35%+279.46%+480.36%
* Price targets were last updated on Jun 9, 2025.

Analyst Ratings

The average analyst rating for REGENXBIO stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy343333
Buy744444
Hold211111
Sell000000
Strong Sell000000
Total1298888

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$52
Strong BuyMaintains$52+480.36%Jun 9, 2025
Goldman Sachs
Goldman Sachs
Hold
Maintains
$14$12
HoldMaintains$14$12+33.93%Apr 17, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$34
Strong BuyReiterates$34+279.46%Mar 21, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$34
Strong BuyReiterates$34+279.46%Mar 20, 2025
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$52
Strong BuyMaintains$52+480.36%Mar 20, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
355.88M
from 83.33M
Increased by 327.08%
Revenue Next Year
293.35M
from 355.88M
Decreased by -17.57%
EPS This Year
-0.06
from -4.59
EPS Next Year
-2.77
from -0.06
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
154.57M470.35M112.72M90.24M83.33M355.88M293.35M332.91M
Revenue Growth
338.70%204.30%-76.03%-19.94%-7.66%327.08%-17.57%13.49%
EPS
-2.982.91-6.50-6.02-4.59-0.06-2.77-2.76
EPS Growth
--------
Forward PE
--------
No. Analysts
-----141410
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High516.6M507.1M571.2M
Avg355.9M293.4M332.9M
Low147.0M184.2M214.2M

Revenue Growth

Revenue Growth20252026202720282029
High
520.0%
42.5%
94.7%
Avg
327.1%
-17.6%
13.5%
Low
76.4%
-48.2%
-27.0%

EPS Forecast

EPS20252026202720282029
High2.840.96-0.92
Avg-0.06-2.77-2.76
Low-3.29-5.36-4.01

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.